advertisement
11.3.4 Betablocker (25)
Showing records 1 to 25
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761
61696 Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry
Ba-Ali S
Frontiers in neurology 2015; 6: 93
61046 The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007
Lin JC
Journal of Glaucoma 2015; 24: 364-371
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Ng XW
Drug delivery and translational research 2015; 5: 469-479
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Liu KL
Drug delivery and translational research 2015; 5: 469-479
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Inoue T
JAMA ophthalmology 2015; 133: 755-761
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Adachi M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61696 Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry
Sander B
Frontiers in neurology 2015; 6: 93
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Yamamoto T
JAMA ophthalmology 2015; 133: 755-761
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Veluchamy AB
Drug delivery and translational research 2015; 5: 469-479
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Hamada N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61696 Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry
Brøndsted AE
Frontiers in neurology 2015; 6: 93
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Lwin NC
Drug delivery and translational research 2015; 5: 469-479
61696 Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry
Lund-Andersen H
Frontiers in neurology 2015; 6: 93
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Honda N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Kuwayama Y
JAMA ophthalmology 2015; 133: 755-761
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Koseki N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Wong TT
Drug delivery and translational research 2015; 5: 469-479
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Abe H; Suganami H
JAMA ophthalmology 2015; 133: 755-761
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Matsuo H
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Venkatraman SS
Drug delivery and translational research 2015; 5: 469-479
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Miyata K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Araie M;
JAMA ophthalmology 2015; 133: 755-761
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Otani SI; Unoki K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
